INSM ▼ -0.0% - Insmed Incorporated
$INSM INSM - Insmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan
19-OCT-2026 07:00 AM ET
Share this post
More filings for $INSM
INSM ▼ -1.8% - Insmed IncorporatedOct 15, 2026INSM ▼ -0.1% - Insmed IncorporatedOct 14, 2026INSM ▼ -4.6% - Insmed IncorporatedOct 5, 2026INSM ▼ -4.6% - Insmed IncorporatedOct 5, 2026INSM ▲ +4.5% - Insmed IncorporatedSep 21, 2026INSM ▲ +0.4% - Insmed IncorporatedSep 16, 2026
View full $INSM filing history →💬 Comments
Loading comments…
Leave a comment